Ascendis Pharma A Income Statement (2012-2025) | ASND

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2012	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.02B	0.00B	0.00B	0.00B	0.02B	0.00B	0.02B	0.02B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.02B	0.02B	0.04B	0.05B	0.05B	0.15B	0.10B	0.04B	0.06B	0.19B	0.11B	0.18B	0.25B
Cost of Revenue																																		0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.02B	0.04B	0.03B
Gross Profit																															0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.02B	0.03B	0.04B	0.04B	0.13B	0.10B	0.03B	0.05B	0.17B	0.09B	0.14B	0.22B
Operating items
Research & Development		-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.02B	-0.02B	-0.02B	0.02B	-0.02B	-0.02B	-0.03B	0.03B	-0.04B	-0.05B	-0.04B	0.04B	-0.06B	-0.05B	-0.05B	0.07B	-0.06B	-0.07B	-0.07B	0.53B	0.11B	0.10B	0.07B	0.08B	0.09B	0.10B	0.10B	0.11B	0.11B	0.11B	0.12B	0.10B	0.08B	0.09B	-0.08B	0.08B	0.09B	0.08B	-0.08B
Share-based Compensation (IS)																															27.86B	19.63B	0.02B		0.02B	0.02B	0.01B		0.01B	0.02B	0.02B		0.02B	0.03B	0.03B		0.03B	0.03B	0.04B
Selling, General & Administrative		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.01B	-0.00B	-0.00B	-0.00B	0.01B	-0.01B	-0.01B	-0.01B	0.02B	-0.01B	-0.01B	-0.01B	0.03B	-0.02B	-0.02B	-0.02B	0.16B	0.04B	0.04B	0.05B	0.06B	0.05B	0.06B	0.06B	0.06B	0.07B	0.08B	0.07B	0.07B	0.07B	0.08B	-0.08B	0.09B	0.11B	0.12B	-0.13B
Operating Expenses		-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.02B	-0.01B	-0.00B	-0.02B	-0.02B	-0.02B	0.03B	-0.03B	-0.03B	-0.04B	0.04B	-0.04B	-0.05B	-0.04B	0.06B	-0.07B	-0.06B	-0.06B	0.10B	-0.08B	-0.09B	-0.10B	0.69B	0.15B	0.14B	0.12B	0.13B	0.15B	0.16B	0.16B	0.17B	0.19B	0.19B	0.19B	0.17B	0.15B	0.17B	-0.16B	0.17B	0.20B	0.20B	-0.21B
Operating Income			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.05B	-0.04B	-0.04B	-0.06B	-0.06B	-0.06B	-0.07B	-0.08B	-0.09B	-0.09B	-0.11B	-0.15B	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	0.41B	-0.11B	-0.06B	0.01B
EBIT			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.05B	-0.04B	-0.04B	-0.06B	-0.06B	-0.06B	-0.07B	-0.08B	-0.09B	-0.09B	-0.11B	-0.15B	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	0.41B	-0.11B	-0.06B	0.01B
Non-operating items
Interest & Investment Income			0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.03B	0.00B	0.02B	0.01B	0.00B	0.03B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.03B	0.06B	0.01B	0.08B	0.02B	0.00B	0.05B	0.04B	0.00B	0.02B	0.00B	0.05B	0.03B	-0.00B	0.03B	0.06B	0.01B
Net income details
EBT			-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.02B	-0.01B	-0.04B	-0.02B	-0.02B	-0.02B	-0.07B	-0.03B	-0.03B	-0.04B	-0.04B	-0.05B	-0.03B	-0.04B	-0.15B	-0.06B	-0.07B	-0.03B	-0.24B	-0.07B	-0.10B	-0.14B	-0.50B	-0.08B	-0.16B	-0.09B	-0.44B	-0.14B	-0.09B	-0.17B	-0.59B	-0.12B	-0.13B	-0.18B	-0.09B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.07B
Tax Provisions			0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	0.00B	0.00B	-0.00B	-0.01B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Profit After Tax			-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	0.03B	-0.03B	-0.04B	-0.04B	-0.05B	-0.03B	-0.04B	-0.04B	-0.06B	-0.07B	-0.03B	-0.39B	0.07B	-0.10B	-0.14B	-0.83B	-0.08B	0.16B	-0.09B	-0.12B	-0.14B	-0.09B	0.17B	-0.21B	-0.12B	-0.13B	-0.18B	-0.09B	-0.14B	-0.12B	0.11B	-0.04B	0.10B	-0.04B	0.07B
Equity Income																							-0.00B	-0.00B	-0.00B	-0.02B	0.00B	-0.00B	-0.00B	-0.02B	-0.03B	-0.01B	-0.00B	0.04B	-0.01B	-0.00B	-0.00B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	0.03B	-0.00B	-0.01B
Income from Continuing Operations			-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.02B	-0.01B	-0.04B	-0.02B	-0.02B	-0.02B	-0.07B	-0.03B	-0.03B	-0.04B	-0.04B	-0.05B	-0.03B	-0.04B	-0.15B	-0.06B	-0.07B	-0.03B	-0.24B	-0.07B	-0.10B	-0.14B	-0.50B	-0.08B	-0.16B	-0.09B	-0.44B	-0.14B	-0.09B	-0.17B	-0.58B	-0.12B	-0.13B	-0.18B	-0.08B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.06B
Consolidated Net Income			-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.02B	-0.01B	-0.04B	-0.02B	-0.02B	-0.02B	-0.07B	-0.03B	-0.03B	-0.04B	-0.04B	-0.05B	-0.03B	-0.04B	-0.15B	-0.06B	-0.07B	-0.03B	-0.24B	-0.07B	-0.10B	-0.14B	-0.50B	-0.08B	-0.16B	-0.09B	-0.44B	-0.14B	-0.09B	-0.17B	-0.58B	-0.12B	-0.13B	-0.18B	-0.08B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.06B
Income towards Parent Company			-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.05B	-0.03B	-0.04B	-0.04B	-0.06B	0.07B	0.03B	-0.39B	0.07B	0.10B	0.14B	-0.83B	-0.08B	0.16B	0.09B	-0.76B	-0.14B	0.09B	0.17B	-0.21B	-0.12B	0.13B	0.18B	-0.10B	-0.14B	0.12B	0.11B	-0.04B	-0.10B	0.05B	0.07B
Net Income towards Common Stockholders			-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.05B	-0.03B	-0.04B	-0.04B	-0.06B	0.07B	0.03B	-0.39B	0.07B	0.10B	0.14B	-0.83B	-0.08B	0.16B	0.09B	-0.76B	-0.14B	0.09B	0.17B	-0.21B	-0.12B	0.13B	0.18B	-0.10B	-0.14B	0.12B	0.11B	-0.04B	-0.10B	0.05B	0.07B
Additional items
EPS (Basic)			-0.03	-0.12	-0.11	-0.26	0.07	-0.70	-0.34	-0.52	-0.90	-0.60	-0.81	-0.70	-0.83	-1.04	-1.22	-1.11	-1.37	-0.65	-0.94	-0.87	-1.45	1.42	0.59	-8.25	1.46	2.18	2.94	-15.81	-1.41	3.01	1.76	-14.05	-2.47	1.54	3.09	-3.71	-2.10	2.33	3.14	-1.65	-2.47	2.02	1.90	-0.71	-1.64	0.75	1.21
EPS (Weighted Average and Diluted)			-0.05	-0.20	-0.18	-0.44	0.06	-0.63	-0.30	-0.50	-0.82	-0.53	-0.72	-4.46	-0.78	-0.94	-1.04	-7.40				-5.70				-61.11				-113.71				-93.31				-30.22				-13.55		1.80				0.63
Shares Outstanding (Weighted Average)		0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.05B	0.05B	0.05B	0.05B	0.05B	0.05B	0.05B	0.05B	0.05B	0.05B	0.05B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B
Shares Outstanding (Diluted Average)	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.00B	0.03B	0.04B	0.04B	0.01B				0.01B				0.01B				0.01B				0.01B				0.01B				0.01B		0.07B				0.07B
EBITDA			-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.05B	-0.03B	-0.04B	-0.04B	-0.06B	-0.07B	-0.03B	-0.09B	-0.07B	-0.10B	-0.14B	-0.17B	-0.07B	-0.16B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.21B	-0.12B	-0.13B	-0.18B	-0.05B	-0.14B	-0.12B	-0.11B	-0.06B	-0.10B	-0.05B	-0.07B
Interest Expenses	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.01B	-0.00B	0.00B	-0.00B	-0.01B	-0.00B	0.00B	-0.01B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	0.00B	0.00B	-0.01B	-0.05B	0.00B	0.00B	0.01B	0.00B	0.00B	0.01B	0.01B	0.04B	0.03B	0.01B	0.01B	0.03B	0.07B	0.08B	0.02B	-0.03B	0.06B	0.05B	0.04B	-0.08B
Tax Rate						7.40%	3.13%	1.85%	2.14%	0.76%	0.57%	0.55%	0.31%		0.06%	0.12%	0.70%	0.54%	0.26%	0.43%	0.29%	0.07%	0.13%	0.11%	0.24%	0.02%	0.12%	0.11%	0.02%	0.00%	0.30%	0.05%		0.03%	0.19%			0.93%			0.40%	7.14%		0.21%	1.04%	2.90%	1.13%	10.99%	6.30%

Research Tools

Ascendis Pharma A Income Statement (2012-2025) | ASND

Create an account

Sign In

Reset Password

Get Pro for 60% off